THERAPEUTIC SLTNS INTL (TSOI)
TSOI moved a median of 0.00% 30 minutes after news, and 0.00% by the close. How TSOI actually reacts to news — the realized, point-in-time move the market made, measured across 62 labeled events over the last three years with zero look-ahead.
TSOI’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 33% | 51 |
| 30-min | 0.00% | 28% | 60 |
| 60-min | 0.00% | 34% | 62 |
| to close | 0.00% | 39% | 62 |
| Middle 50% of TSOI reactions | -6.67% to +5.34% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 62 |
Half of all THERAPEUTIC SLTNS INTL news events land between -6.67% and +5.34% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when TSOI moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to TSOI's baseline. Nothing else.
Recent TSOI events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 15-12G THERAPEUTIC SOLUTIONS | SEC filing · Form 15-12G | SEC EDGAR | — | +33.33% | |
| Form 25 THERAPEUTIC SOLUTIONS | SEC filing · Form 25 | SEC EDGAR | +0.00% | +0.00% | |
| Form 8-K THERAPEUTIC SOLUTIONS For: Apr 23 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +50.00% | |
| Therapeutic Solutions International to Voluntarily Delist | Press release | Business Wire | +0.00% | +50.00% | |
| Form NT 10-K THERAPEUTIC SOLUTIONS For: Dec 31 | SEC filing · Form NT | SEC EDGAR | +0.00% | +0.00% | |
| Form 8-K THERAPEUTIC SOLUTIONS For: Feb 28 | SEC filing · Form 8-K | SEC EDGAR | -16.67% | -16.67% | |
| Form 8-K THERAPEUTIC SOLUTIONS For: Feb 15 | SEC filing · Form 8-K | SEC EDGAR | -16.67% | +0.00% | |
| Form 8-K THERAPEUTIC SOLUTIONS For: Jan 07 | SEC filing · Form 8-K | SEC EDGAR | — | -33.33% | |
| Form 8-K THERAPEUTIC SOLUTIONS For: Nov 25 | SEC filing · Form 8-K | SEC EDGAR | +16.67% | -16.67% | |
| Form 10-Q THERAPEUTIC SOLUTIONS For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | — | -5.88% | |
| Form NT 10-Q THERAPEUTIC SOLUTIONS For: Sep 30 | SEC filing · Form NT | SEC EDGAR | +0.00% | +0.00% | |
| Form 10-Q THERAPEUTIC SOLUTIONS For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +16.67% | +0.00% | |
| Form NT 10-Q THERAPEUTIC SOLUTIONS For: Jun 30 | SEC filing · Form NT | SEC EDGAR | -14.29% | +0.00% | |
| Form 8-K THERAPEUTIC SOLUTIONS For: Jun 28 | SEC filing · Form 8-K | SEC EDGAR | -5.56% | -11.11% | |
| Form 8-K THERAPEUTIC SOLUTIONS For: Jun 28 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -11.11% | |
| Form 8-K THERAPEUTIC SOLUTIONS For: May 31 | SEC filing · Form 8-K | SEC EDGAR | +5.56% | +0.00% | |
| Form 8-K/A THERAPEUTIC SOLUTIONS For: May 31 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.00% | |
| Form 10-Q THERAPEUTIC SOLUTIONS For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +6.67% | +6.67% | |
| Therapeutic Solutions International Receives Notice of Allowance for Landmark Patent Covering Cellular Therapy of Lung Diseases | Press release | Business Wire | -11.11% | -11.11% | |
| Form NT 10-Q THERAPEUTIC SOLUTIONS For: Mar 31 | SEC filing · Form NT | SEC EDGAR | — | +21.43% | |
| Immunology Based Suicide Prevention Company Campbell Neurosciences Announces Appointment of Public Company Veteran Raymond Oliver as Chairman of the Board | Press release | Business Wire | +20.00% | +10.00% | |
| Form 8-K THERAPEUTIC SOLUTIONS For: May 03 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +33.33% | |
| Form 10-K THERAPEUTIC SOLUTIONS For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -11.11% | -22.22% | |
| Form NT 10-K THERAPEUTIC SOLUTIONS For: Dec 31 | SEC filing · Form NT | SEC EDGAR | — | +22.22% | |
| Therapeutic Solutions International Granted Patent on Commercially Available QuadraMune® Nutraceutical for Increasing Natural Killer Cell Immunity in COVID-19 Patients | Press release | Business Wire | +0.00% | +9.09% | |
| Therapeutic Solutions International Announces Landmark Finding Regarding Mechanism of Action of its JadiCell Stem Cell Product | Press release | Business Wire | +0.00% | -10.00% | |
| Therapeutic Solutions International Files Patent on “Facilitating Effects” of JadiCells on Gene Therapy Mediated Cell Differentiation | Press release | Business Wire | +0.00% | +16.67% | |
| Form 8-K THERAPEUTIC SOLUTIONS For: Feb 21 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -5.00% | |
| Form 8-K THERAPEUTIC SOLUTIONS For: Feb 20 | SEC filing · Form 8-K | SEC EDGAR | +10.00% | +5.00% | |
| Form EFFECT THERAPEUTIC SOLUTIONS | SEC filing · Form EFFECT | SEC EDGAR | -1.67% | -6.25% | |
| Form S-1/A THERAPEUTIC SOLUTIONS | SEC filing · Form S-1 | SEC EDGAR | +0.00% | -7.62% | |
| Form 8-K THERAPEUTIC SOLUTIONS For: Jan 22 | SEC filing · Form 8-K | SEC EDGAR | +7.69% | +7.69% | |
| Therapeutic Solutions International Files Lawsuit in San Diego Superior Court to Obtain Identities of Certain Individuals or Entities | Press release | Business Wire | — | +0.00% | |
| Form S-1 THERAPEUTIC SOLUTIONS | SEC filing · Form S-1 | SEC EDGAR | +0.00% | +7.69% | |
| Therapeutic Solutions International Launches Adult Stem Cell Therapy Company Focused on Curing Epilepsy | Press release | Business Wire | +0.00% | -3.33% | |
| Form RW THERAPEUTIC SOLUTIONS | SEC filing · Form RW | SEC EDGAR | +0.00% | -6.25% | |
| Form POS AM THERAPEUTIC SOLUTIONS | SEC filing · Form POS | SEC EDGAR | +8.33% | +8.33% | |
| Therapeutic Solutions International Subsidiary Immunotherapy Company Res Nova Bio, Inc. Announces Positive Data on First Four Advanced Cancer Patients Treated with FloraStilbene™ | Press release | Business Wire | +9.09% | +9.09% | |
| Form 8-K THERAPEUTIC SOLUTIONS For: Dec 22 | SEC filing · Form 8-K | SEC EDGAR | +9.09% | +9.09% | |
| Therapeutic Solutions International Announces Formation of ALS Biologics Inc to Commercialize Regenerative Technologies Related to Dreaded Motor Neuron Disease | Press release | Business Wire | -9.09% | -9.09% | |
| Therapeutic Solutions International and Campbell Neurosciences Publish on Nutritional Modulation of the Indolamine 2,3 Dioxygenase Pathway as a Non-Toxic Means of Addressing Depression | Press release | Business Wire | +0.00% | +0.00% | |
| Therapeutic Solutions International Collaborates on Peer-Reviewed Publication on Personalized Immunotherapy for Brain Cancer Using mRNA | Press release | Business Wire | +0.00% | +0.00% | |
| Form 10-Q THERAPEUTIC SOLUTIONS For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | — | -7.69% | |
| Res Nova Biologics Announces First Cancer Patient Treated with FloraStilbene™ | Press release | Business Wire | +11.54% | +15.38% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the TSOI section they belong to.
Where else TSOI is measured.
TSOI earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Biosyent Inc (RX_CDNX) | 62 | 0.00% | 33% |
| Seagen Inc. (SGEN) | 62 | -0.01% | 48% |
| GREEN CURES & BOTANICAL (GRCU) | 61 | 0.00% | 47% |
| Selecta Biosciences, Inc. (SELB) | 61 | -0.80% | 17% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is THERAPEUTIC SLTNS INTL's median reaction calculated?
Every labeled TSOI news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 62 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 28% of TSOI's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does TSOI's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.